# TABRECTA
> **NDA213591** · New Drug Application · Sponsor: NOVARTIS PHARM · Approved 2020-05-06
## Drug
- **FDA Application Number:** NDA213591
- **Application type:** New Drug Application
- **Brand name:** TABRECTA
- **Generic name:** CAPMATINIB
- **Active ingredients:** CAPMATINIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS PHARM
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2020-05-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213591)
---
*MORVS · CC0 1.0*